Condition
Pleural Mesothelioma|Malignant Pleural Mesothelioma
Estimated Enrollment: 85
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment
Study ID Numbers: 03-302
Study First Received: September 12, 2005
Last Updated: March 26, 2014
Estimated Primary Completion Date: July 2006
Primary Outcome Measures:
To monitor tumor recurrence and patient survival, and compare those results to historic controls.|To document the morbidity and mortality of this treatment protocol in this patient population|to evaluate the pharmacokinetics of cisplatin.
Sponsors and Collaborators:
Dana-Farber Cancer Institute|Brigham and Women’s Hospital
Website Link: https://ClinicalTrials.gov/show/NCT00165516
